To The Moon

$CVS Health(CVS)$ 4Q YoY
Revenue +9.5%
Net Income +76% (Adj flat)
Dil. Eps +79% (Ajd. +1%)

FY22
OCF -11% (mostly inventories)
FCF -20%

CVS 2023 guidance

That Cash flow from Operation at $12.5 to $13.5 is getting annoying (low ball again?) or one day it will happen?

it was $16.2 B in FY22This was CVS guidance over 3Q
Revenue actuals of $322
They seem to consistently under promise (IMaO)

CVS cash flow with FY22 completed

FCF decline 15% ( due to inventory & prescriptions)
Dividend payout at 17%CVS FCF/share

with FCF declining, FCF per share is at the same level of FY20CVS with a proposed $10.6 B acquisition of Oak Street Health

$39 per share

Expected to close in 2023

Current Oak Street CEO Mike Pykosz will continue to lead

Oak Street health will add $2 B in revenue to CVS

Not profitable today and with negative FCFPath to profitability"CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion"

CVS had $20 B in cash/eqv at the end of 3Q. 

CVS balance sheet looks ready for the $8 B acquisition of Signify with $20 B in cash&eqv+ST inv.

And room for buybacks

https://twitter.com/DividendWave/status/1623425824660590592